|
Volumn 17, Issue 16, 2003, Pages 1909-1914
|
Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of Aplidin®, a novel marine-derived antineoplastic agent, in human plasma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALIBRATION;
LIQUID CHROMATOGRAPHY;
PLASMA (HUMAN);
QUALITY CONTROL;
ACCURACY AND PRECISION;
ANTINEOPLASTIC AGENTS;
CALIBRATION STANDARD;
DEPSIPEPTIDES;
HUMAN PLASMAS;
LIMITS OF QUANTITATIONS;
LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY ASSAYS;
LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY;
MULTIPLE REACTION MONITORING;
SENSITIVE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY;
MASS SPECTROMETRY;
APLIDIN;
DEHYDRODIDEMNIN B;
DIDEMNIN B;
ACCURACY;
ANALYTIC METHOD;
ARTICLE;
CALIBRATION;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DRUG DETERMINATION;
HUMAN;
LIQUID CHROMATOGRAPHY;
QUALITY CONTROL;
TANDEM MASS SPECTROMETRY;
VALIDATION PROCESS;
|
EID: 0043029937
PISSN: 09514198
EISSN: None
Source Type: Journal
DOI: 10.1002/rcm.1133 Document Type: Article |
Times cited : (9)
|
References (14)
|